Skip to content

Application of esketamine in knee arthroscopy under opioid free general anaesthesia with laryngeal mask

Application of esketamine in knee arthroscopy under opioid free general anaesthesia with laryngeal mask

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095887
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee joint disease

Interventions

Esmketamine group(part ?):Induction of anaesthesia: propofol 1.5 mg/kg, esketamine 1x ED95 mg/kg
Remifentanil group(part ?):Induction of anaesthesia: propofol 1.5mg/kg, remifentanil 1ug/kg
Esmketamine combined with small dose of propofol (1.5mg/kg) was the 50% effective dose for successful LMA insertion group(part ?):Induction of anaesthesia: propofol 1.5mg/kg, 2 minutes later intraveno

Sponsors

Tianjin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.age 18-65 years old; 2.BMI18~30kg/m2; 3..American Society of Anesthesiologists (ASA) classification I to? ;4.Patients with knee arthroscopic meniscus cleaning or knee arthroscopic free body removal;

Exclusion criteria

Exclusion criteria: 1. severe cardiovascular disease;2. severe respiratory disease;3.recent history of analgesic and sedative use; 4. history of psychiatric disorders; 5.allergy to ketamine or contraindication to its use; 6. cervical spine limitation of movement; 7. the opening is less than two fingers to anticipate the difficulty of laryngeal mask placement

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting;Successful placement of the laryngeal mask;

Secondary

MeasureTime frame
Vital signs at different times (mean arterial pressure, heart rate);

Countries

China

Contacts

Public ContactLi Hongwei

Tianjin Hospital

hongv1986@163.com+86 182 0264 3428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026